Anika Buchholz

Anika Buchholz is a Research Fellow at the Institute of Medical Biometry and Epidemiology, part of the Faculty of Medicine at the University of Hamburg (Universitätsklinikum Eppendorf). Her work focuses on medical biometry, epidemiology, and statistical methodology applied to clinical research, particularly in cardiology, oncology, and healthcare outcomes. She holds a 2022 certification in medical biometrics from the German Society for Medical Informatics, Biometrics, and Epidemiology (GMDS) and the International Biometric Society, German Region (IBS-DR).

• Key Research Areas: Biostatistics, clinical trial design, survival analysis, and risk factor modeling.
• Notable Projects: Contributions to the German Atrial Fibrillation Network (AFNET) registry, NORDIC ICD trial analyses, and oncology interventions (e.g., BENITA trial for ovarian cancer patients).

Her research spans drug efficacy evaluations (e.g., proton-pump inhibitors in liver cirrhosis), device performance (ICD shock efficacy), and interdisciplinary studies in neurology (aneurysm recurrence) and psychiatry (auditory hallucination therapies). She has authored over 20 peer-reviewed articles since 2011, addressing methodological challenges in clustered data analysis and competing risks frameworks.

Awards: Zertifikat „Biometrie in der Medizin“ (2022).

Collaborations involve multicenter trials, including work with the European Liquid Biopsy Society (ELBS) and institutions such as Charité Berlin and the University Heart Center Hamburg.